1:01 PM
 | 
Jan 02, 2018
 |  BC Extra  |  Financial News

NexImmune raises $23M series A

NexImmune Inc. (Gaithersburg, Md.) raised $23 million in a series A round co-led by new investor ArrowMark Partners and existing investor Barer & Son Capital. Existing investor Piedmont Capital also participated.

The immuno-oncology company expects the round to fund...

Read the full 173 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >